Ticker Details
Medicinova Inc MediciNova Inc is a biopharmaceutical company. It is engaged in acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs.
IPO Date:	December 7, 2006
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$69.89M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.12 | 2.67%
Avg Daily Range (30 D):	$0.03 | 2.23%
Avg Daily Range (90 D):	$0.04 | 2.41%

Institutional Daily Volume
Avg Daily Volume:	.13M
Avg Daily Volume (30 D):	.05M
Avg Daily Volume (90 D):	.06M

Trade Size
Avg Trade Size (Sh.):	177
Avg Trade Size (Sh.) (30 D):	158
Avg Trade Size (Sh.) (90 D):	167

Institutional Trades
Total Institutional Trades:	59
Avg Institutional Trade:	$1.84M
Avg Institutional Trade (30 D):	$.57M
Avg Institutional Trade (90 D):	$.55M
Avg Institutional Trade Volume:	.29M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.19M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	538.88K

News

Mar 16, 2026 @ 11:00 AM MediciNova to Participate at the 38th Annual ROTH ... Source: Medicinova, Inc.

Jan 29, 2026 @ 11:00 PM MediciNova Announces 100 Patients Enrolled in SEAN... Source: Medicinova, Inc.

Dec 8, 2025 @ 11:00 AM MediciNova Announces Update and Basic Characterist... Source: Medicinova, Inc.

Dec 1, 2025 @ 11:00 PM Message from the CEO to MediciNova Shareholders Source: Yuichi Iwaki, M.D., Ph.D.

Nov 6, 2025 @ 11:00 PM MediciNova Wins Contract Research and Development ... Source: Medicinova, Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.24	$-.05	$-.24
Diluted EPS	$-.24	$-.05	$-.24
Revenue	$.41M	$.15M	$.41M
Gross Profit
Net Income / Loss	$-12M	$-2.8M	$-12M
Operating Income / Loss	$-13.28M	$-3.09M	$-13.28M
Cost of Revenue
Net Cash Flow	$-9.57M	$-9.57M	$-9.57M
PE Ratio

Splits
Oct 31, 2006	1:10